Photo by impulsq from unsplash
To evaluate the efficacy, safety, and tolerability of perampanel, a selective, non‐competitive, α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) receptor antagonist, as an adjunctive treatment for patients with refractory partial‐onset seizures (POS) from Asia‐Pacific. Click to show full abstract
To evaluate the efficacy, safety, and tolerability of perampanel, a selective, non‐competitive, α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) receptor antagonist, as an adjunctive treatment for patients with refractory partial‐onset seizures (POS) from Asia‐Pacific.
Keywords:
asia pacific;
adjunctive perampanel;
partial onset;
onset seizures;
perampanel partial
Journal Title: Acta Neurologica Scandinavica
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Neurologica Scandinavica
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!